Clinical trial
Assessment of Continuous Measurement of Transcutaneous CO2 for Evaluation of Alveolar Dead Space During Exercise.
NCT03718780 is registered in ClinicalTrials.gov with Centre Hospitalier Metropole Savoie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Continuous Measurement of Transcutaneous CO2 for Evaluation of Alveolar Dead Space During Exercise.
- Lead sponsor
- Centre Hospitalier Metropole Savoie
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 22, 2019
- Completion date
- December 31, 2023
- Enrollment
- 140 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
chronic heart failure, healthy, hyperventilation syndrome, lung diseases, interstitial, pulmonary arterial hypertension, pulmonary disease, chronic obstructive